Loading patent…
AssigneesAgriculture Victoria Services PTY LTD, Murray Goulburn Co-Operative Co., Limited
InventorsMatthew McDonagh, Benjamin Cocks, Angus Tester, Peter Hobman, Andrew Brown, Michelle Rowney
Estimating the term…
The invention provides a method of treating a disorder characterized by elevated or dysregulated myostatin, disorders where the interaction between follistatin and angiogenin can be used to improve function in tissues, neurological diseases or disorders, spinal injuries or diseases, bone diseases or disorders, diseases involving glucose homeostasis, wound healing, neuroprotection, nervous system functional support or managing metabolic diseases, the method comprising administering an effective amount of angiogenin or an angiogenin agonist. Compositions and neutraceuticals comprising angiogenin are also provided.
A method of promoting differentiation of myoblasts into myotubes in a healthy individual, the method comprising administering an effective amount of a composition comprising angiogenin to the healthy individual, wherein the composition comprises angiogenin as the only active ingredient or the composition is a milk fraction in which the concentration of angiogenin is at least 10 times its concentration in bovine milk and is depleted for lactoferrin and lactoperoxidase.
A method of promoting muscle growth, improving muscle strength, increasing the proportion of muscle, improving exercise tolerance, or improving recovery of muscle from use or injury in a healthy individual, the method comprising administering an effective amount of a composition comprising angiogenin to the healthy individual, wherein the composition comprises angiogenin as the only active ingredient or the composition is a milk fraction in which the concentration of angiogenin is at least 10 times its concentration in bovine milk and is depleted for lactoferrin and lactoperoxidase.
A method of increasing muscle tissue in a livestock animal, the method comprising administering to the animal an effective amount of a composition comprising angiogenin to the livestock animal, wherein the composition comprises angiogenin as the only active ingredient or the composition is a milk fraction in which the concentration of angiogenin is at least 10 times its concentration in bovine milk and is depleted for lactoferrin and lactoperoxidase.
Dependencies are inferred from the claim text.